As of Jun 26
| +0.16 / +2.17%|
The 3 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 9.00. The median estimate represents a +32.63% increase from the last price of 7.54.
The current consensus among 3 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.